Get started
Author

Renee A.G. Lijnen

Observed names: R. Lijnen, R.A.G. Lijnen, Renee A. G. Lijnen
ORCID: 0009-0003-4602-979X
Observed ORCID: 0009-0003-4602-979X
OpenAlex ID: A5128285309
Refining BCG ‐failure classifications in non‐muscle‐invasive bladder cancer
2026 · Aleksander Ślusarczyk, Pietro Scilipoti, et al. · British Journal of Urology · 4
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer
2026 · Renee A.G. Lijnen, Joanneke B. Ringia, et al. · European Urology Oncology · 2
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non–muscle-invasive Bladder Cancer: An International Multicenter Analysis
2026 · Aleksander Ślusarczyk, Marco Moschini, et al. · European Urology Oncology · 1
PDF
[ 18 F] fluorodeoxyglucose PET/CT refines staging and treatment selection in high‐risk upper tract urothelial carcinoma
2026 · Renee A. G. Lijnen, Joanneke B. Ringia, et al. · British Journal of Urology
PDF
Diagnostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in staging histological subtypes of invasive bladder cancer
2026 · Renee A. G. Lijnen, Joanneke B. Ringia, et al. · Tijdschrift voor Urologie
PDF
Clinical impact of routine second‑opinion reading of [¹⁸F]FDG‑PET/CT in newly diagnosed invasive bladder cancer: A multicentre study in a centralised referral network
2026 · Renee A. G. Lijnen, Misha L. Vierling, et al. · European Journal of Nuclear Medicine and Molecular Imaging
PDF
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer
2026 · Aleksander Ślusarczyk, Marco Moschini, et al. · Annals of Surgical Oncology
Routine annual imaging does not aid in diagnosing new functional complications more than five years after RC with ileal conduit
2026 · Joanneke B. Ringia, Femke E. F. Scholte, et al. · Tijdschrift voor Urologie
PDF
A0872 Diagnostic value of [¹⁸F]FDG-PET/CT in staging histological subtypes of invasive bladder cancer
2026 · R. Lijnen, J.B. Ringia, et al. · European Urology
P0212 Refining the classification of BCG Failure in non-muscle-invasive bladder cancer: An exploration of the IBCG definitions within an international multicenter cohort
2026 · A. Ślusarczyk, P. Scilipoti, et al. · European Urology
A0626 Naloxegol does not improve gastrointestinal recovery after radical cystectomy within contemporary ERAS protocols: A multicenter prospective cohort study
2026 · J. Ringia, M. Dekker, et al. · European Urology
A0073 Development and validation of a model to predict BCG-unresponsiveness in highgrade non-muscle-invasive bladder cancer: An international multicenter study
2026 · A. Ślusarczyk, M. Moschini, et al. · European Urology
P0471 Diagnostic value and clinical impact of staging [¹⁸F]FDG-PET/CT for upper tract urothelial carcinoma
2026 · R. Lijnen, J.B. Ringia, et al. · European Urology
Works count: 13
Citation count: 7
H-index: 2
I10-index:
Year
Topic
Type